世界の小分子滅菌注射薬市場 – 業界動向と2031年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare 世界の小分子滅菌注射薬市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

世界の小分子滅菌注射薬市場 – 業界動向と2031年までの予測

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60
Buy Now 今すぐ購入

世界の小分子滅菌注射薬市場、製品別（バイアル充填、シリンジ充填、カートリッジ充填、小分子抗生物質、化学療法剤、局所および全身麻酔薬、骨格筋弛緩薬、鎮痛剤、抗凝固薬、抗けいれん薬、抗ウイルス薬、抗ヒスタミン薬/抗アレルギー薬、その他）、投与経路（静脈内（IV）、筋肉内（IM）、皮下（SC））、用途（腫瘍学、感染症、心血管疾患、代謝性疾患、神経学、皮膚科、泌尿器科、自己免疫疾患、呼吸器疾患、感染症、中枢神経系疾患、血液疾患、筋骨格疾患、その他）、エンドユーザー（病院、専門クリニック、在宅ケア環境、その他）、流通チャネル（直接入札、小売薬局、オンライン薬局など）– 2031 年までの業界動向と予測。

 低分子滅菌注射薬市場

低分子滅菌注射薬市場の分析と規模

低分子滅菌注射薬は、薬剤を血流に直接送り込み、迅速かつ正確な治療効果を保証するために不可欠です。病院や診療所で広く使用されているこれらの薬剤は、感染症、疼痛管理、集中治療などのさまざまな症状を治療し、緊急時や臨床現場で命を救う介入を提供します。                      

データブリッジマーケットリサーチは、2023年に1,56,774.14百万米ドルであった世界の小分子滅菌注射薬市場は、2031年までに2,73,421.52百万米ドルに達し、2024年から2031年の予測期間中に7.2％のCAGRを達成すると予測しています。これは、市場価値を示しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジマーケットリサーチがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

低分子滅菌注射薬市場の範囲とセグメンテーション

レポートメトリック

詳細

予測期間

2024年から2031年

基準年

2023

歴史的な年

2022 (2016～2021年にカスタマイズ可能)

定量単位

売上高（百万米ドル）、販売数量（個数）、価格（米ドル）

対象セグメント

製品 (バイアル充填、シリンジ充填、カートリッジ充填、低分子抗生物質、化学療法剤、局所麻酔薬および全身麻酔薬、骨格筋弛緩薬、鎮痛薬、抗凝固薬、抗けいれん薬、抗ウイルス薬、抗ヒスタミン薬/抗アレルギー薬、その他)、投与経路 (静脈内 (IV)、筋肉内 (IM)、皮下 (SC))、用途 (腫瘍学、感染症、心血管疾患、代謝性疾患、神経学、皮膚科、泌尿器科、自己免疫疾患、呼吸器疾患、感染症、中枢神経系疾患、血液疾患、筋骨格系疾患、その他)、エンドユーザー (病院、専門クリニック、在宅ケア施設、その他)、流通チャネル (直接入札、小売薬局、オンライン薬局、その他)

対象国

北米では米国、カナダ、メキシコ、ヨーロッパではドイツ、フランス、英国、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、その他のヨーロッパ諸国、アジア太平洋地域 (APAC) では中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC)、中東およびアフリカ (MEA) の一部としてサウジアラビア、UAE、南アフリカ、エジプト、イスラエル、その他の中東およびアフリカ (MEA)、南米の一部としてブラジル、アルゼンチン、その他の南米。

対象となる市場プレーヤー

Gilead Sciences, Inc. (米国)、BioCryst Pharmaceuticals, Inc. (米国)、AstraZeneca (英国)、Genentech, Inc. (米国)、Merck KGaA (ドイツ)、Hikma Pharmaceuticals PLC (英国)、AbbVie Inc. (米国)、American Regent, Inc. (米国)、Amgen Inc. (米国)、Bristol-Myers Squibb Company (米国)、Teligent. (米国)、エーザイ株式会社 (日本)、Teva Pharmaceutical Industries Ltd. (イスラエル)、Neuren Pharmaceuticals (オーストラリア)、Noxopharm (オーストラリア)、Amomed Pharma GmbH (オーストリア)、Sanofi (フランス)、Exelixis, Inc. (米国)、Fresenius Kabi USA (米国)、Pfizer Inc. (米国)

市場機会
  • 患者の服薬コンプライアンス向上のための簡便な注射薬の需要
  • 高齢化社会における医療ニーズの高まり

市場の定義

低分子滅菌注射薬は、非経口投与用に設計された低分子量の医薬品化合物です。これらの薬剤は、多くの場合液体状で、滅菌されており、体内に直接注入されるため、吸収が速く、効果があります。さまざまな治療クラスを網羅しており、幅広い病状の治療に使用されます。            

世界の小分子滅菌注射薬市場の動向

ドライバー

  • 慢性疾患の増加には 効果的な治療が必要

糖尿病、心血管疾患、がんなどの慢性疾患の負担が増大し、効果的な治療法の必要性が浮き彫りになっています。低分子の滅菌注射薬は標的療法を提供するため需要が高く、これらの疾患の管理や慢性疾患に関連する医療上の課題の増大への対処に利用されています。

  • Advancements in Biotechnology Expanding Treatment Options

Technological innovations in biotechnology drive the development of novel small molecule injectables, enhancing efficacy, safety, and targeted delivery. These advancements expand treatment options, fueling market growth by meeting diverse therapeutic needs with more effective and precise pharmaceutical solutions.

Opportunities

  • Demand for Convenience Injectable Drugs for Improved Patient Compliance

The demand for small molecule sterile injectable drugs is propelled by preferences for convenience, rapid onset of action, and improved patient compliance, especially in managing diseases requiring frequent dosing. These factors drive market growth, as injectables offer efficient and effective treatment options for patients.

  • Increasing Healthcare Needs for Aging Population

The growing aging population worldwide drives demand for small molecule sterile injectable drugs tailored to age-related conditions such as osteoporosis and arthritis. This demographic shift fuels market expansion as pharmaceutical companies respond to the increasing healthcare needs of the elderly, offering effective treatments for geriatric health concerns. 

Restraints/Challenges

  • Shortages and Supply Chain Risks Lead to Drug Scarcities

Disruptions such as raw material shortages and production capacity constraints can lead to drug scarcities, impacting patient access to essential medications. Shortages and supply chain risks pose significant challenges in the small molecule sterile injectable drugs market, risking the availability of vital treatments and exacerbating healthcare disparities.  

  • Risk of Contamination in Product

Despite stringent measures, microbial contamination risks persist in small molecule sterile injectable drugs, risking product safety and efficacy. This concern undermines consumer trust, leading to potential product recalls, adverse events, and reputational damage for manufacturers, hindering market confidence and impeding business growth. 

This global small molecule sterile injectable drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global small molecule sterile injectable drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2022, The FDA greenlights tremelimumab alongside durvalumab and platinum-based chemotherapy for metastatic non-small cell lung cancer in adults. This approval offers a promising treatment option, reflecting advancements in combating NSCLC and providing hope for improved patient outcomes and enhanced survival rates
  • In 2022, The FDA approves Eli Lilly's Mounjaro (tirzepatide) injection, a novel once-weekly GIP and GLP-1 receptor agonist, to enhance glycemic control in adults with type 2 diabetes. This approval marks a significant milestone in diabetes management, offering a convenient and effective treatment option for patients seeking better glucose regulation
  • In 2021, Novartis revealed that branaplam, a small drug molecule, had entered Phase 2 clinical trials for spinal muscular atrophy, marking a significant advancement in potential treatment options for this debilitating condition
  • In January 2020, Sanofi S.A acquired Syntrox to bolster biotechnological product development for cancer and autoimmune disorders. This strategic acquisition is anticipated to contribute to advancements in therapeutic solutions, potentially fostering growth in the small molecule sterile injectable drugs market by expanding treatment options for various medical conditions

Global Small Molecule Sterile Injectable Drugs Market Scope

The global small molecule sterile injectable drugs market is segmented on the basis of product, route of administration, application, end-users, and distribution channels. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Vial Filling
  • Syringe Filling
  • Cartridge Filling
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Local and General Anaesthetics
  • Skeletal Muscle Relaxants
  • Analgesics
  • Anticoagulants
  • Anticonvulsants
  • Antivirals
  • Anti-histamines/ Anti-allergy
  • Others

 Route of Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)

 Application

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Neurology
  • Dermatology
  • Urology
  • Autoimmune Diseases
  • Respiratory Disorders
  • Infectious Diseases
  • CNS Diseases
  • Blood Disorders
  • Musculoskeletal Disorders
  • Others

 End-Users

  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Others

 Distribution Channels

  • Direct Tender
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Global Small Molecule Sterile Injectable Drugs Market Regional Analysis/Insights

The global small molecule sterile injectable drugs market is analysed and market size insights and trends are provided by country, product, route of administration, application, end-users, and distribution channels as referenced above.

The countries covered in the global small molecule sterile injectable drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the small molecule sterile injectable drugs market, with the vial filling segment projected to exhibit the highest growth rate in the U.S. during 2021-2028. This growth is driven by the rising geriatric population, highlighting the demand for injectable medications and sterile vial filling solutions.

Europe is expected to lead the small molecule sterile injectable drugs market, with the vial filling segment dominating in Germany. This dominance is attributed to advancements in technology, reflecting Germany's commitment to innovation and its pivotal role in shaping the landscape of sterile injectable drug manufacturing in Europe.

Asia Pacific is expected to dominate the small molecule sterile injectable drugs market, with China leading the vial filling segment. The country boasts the highest number of providers for such drugs, propelling growth in the region's market and reinforcing its position as a key player in pharmaceutical manufacturing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global small molecule sterile injectable drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global small molecule sterile injectable drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global small molecule sterile injectable drugs market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Small Molecule Sterile Injectable Drugs Market Share Analysis

世界の小分子滅菌注射薬市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、世界の小分子滅菌注射薬市場に関連する会社の焦点にのみ関連しています。

世界の低分子滅菌注射薬市場で活動している主要企業は次のとおりです。

  • ギリアド・サイエンシズ（米国）
  •  バイオクリストファーマシューティカルズ社（米国）
  • アストラゼネカ（英国）
  •  ジェネンテック社（米国）
  •  メルクKGaA（ドイツ）
  • ヒクマ・ファーマシューティカルズPLC（英国）
  •  アッヴィ社（米国）
  •  アメリカン・リージェント社（米国）
  •  アムジェン社（米国）
  •  ブリストル・マイヤーズスクイブ社（米国）
  •  テリジェント（米国）
  •  エーザイ株式会社（日本）
  •  テバ製薬工業株式会社（イスラエル）
  •  ニューレン・ファーマシューティカルズ（オーストラリア）
  •  ノキソファーム（オーストラリア）
  •  Amomed Pharma GmbH (オーストリア)
  •  サノフィ（フランス）
  •  エクセリクシス社（米国）
  •  フレゼニウス カビ USA (米国)
  •  ファイザー社（米国）

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Small molecule sterile injectable drugs market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. Product LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET end user COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. Pestel Analysis
    2. Porter's Analysis
  5. REGULATORY FRAMEWORK
    1. REGULATORY GUIDANCE AS PER U.S. FDA.
    2. REGULATORY SCENARIO FOR EUROPEAN UNION
    3. REGULATORY SCENARIO IN JAPAN
    4. REGULATORY FRAMEWORK IN CHINA
  6. Pipeline analysis
  7. Market Overview
    1. DRIVERS
      1. IncreASing Prevalence of chronic diseaseS
      2. PRODUCT APPROVAl of small molecule
      3. High R&D Investment for small molecule developemnt
      4. Strong pipeline for Small molecule injectable
      5. growth in generic injectables
    2. RESTRAINTS
      1. High LEVEL OF QUALITY AND CARE REQUIRED in the PRODUCTION
      2. High manufacturing and purchasING cost of injectableS
      3. Stringent regulations for facilites and equipments required for small molecules injectable
      4. product recall
    3. OPPORTUNITIES
      1. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      2. Growing product launches
      3. Rising per captia income and healthcare expenditure
    4. CHALLENGEs
      1. Lack of accessibility
      2. High Cost of Diagnosis & Treatment
  8. IMPACT OF COVID-19 ON THE Global Small Molecule Sterile Injectable Drugs Market
    1. OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
    2. IMPACT ON price
    3. impact on demand
    4. IMPACT ON SUPPLY CHAIN
    5. STRATEGIC DECISIONS of Government and MANUFACTURERS
    6. Conclusion
  9. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT
    1. overview
    2. vial filling
    3. syringe filling
    4. cartridge filling
    5. OTHERS
  10. global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY application
    1. overview
    2. oncology
    3. infectious diseases
    4. cardiovascular diseases
    5. metabolic diseases
    6. neurology
    7. urology
    8. dermatology
    9. autoimmune diseases
    10. respiratory disorders
    11. others
  11. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY end user
    1. overview
    2. hospitals
    3. specialty clinics
    4. homecare setting
    5. others
  12. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail pharmacy
    4. online pharmacy
    5. others
  13. GLOBAL small molecule sterile injectable drugs market, by REGION
    1. overview
    2. ASIA-PACIFIC
      1. China
      2. Japan
      3. India
      4. Australia
      5. South Korea
      6. Singapore
      7. New Zealand
      8. Thailand
      9. Malaysia
      10. Indonesia
      11. Philippines
      12. Vietnam
      13. Rest of Asia-Pacific
    3. EUROPE
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Netherlands
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Sweden
      12. Denmark
      13. PolaNd
      14. REST OF Europe
    4. MIDDLE EAST AND AFRICA
      1. South Africa
      2. Saudi Arabia
      3. U.A.E.
      4. Egypt
      5. Israel
      6. Ethiopia
      7. Rest of Middle East & Africa
    5. north america
      1. U.S.
      2. CANADA
      3. mexico
    6. SOUTH AMERICA
      1. Brazil
      2. ARGENTINA
      3. rest of south america
  14. GLOBAL small molecule sterile injectable drugs Market, COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  15. Swot analysis
  16. Company profile
    1. PFIZER INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. SERVICE PORTFOLIO
    2. GILEAD SCIENCES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Fresenius Kabi USA (Asubsidiary of Fresenius SE & Co. KGaA).
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. AbbVie Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. American regent, inc. (a daiichi sankyo group company)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Amomed Pharma GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Astrazeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. biocryst pharmaceuticals, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Bristol-Myers Squibb Company
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Eisai Co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Exelixis, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. Genentech, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Hikma Pharmaceuticals PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Neuren Pharmaceuticals
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Noxopharm
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. Sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. Teligent
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

表のリスト

TABLE 1 Global Small Molecule Sterile Injectable DrugS Market, pipeline analysis

TABLE 2 Number of people with diabetes (Million) among ages 20–79 years

TABLE 3 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 Years)

TABLE 4 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By PRODUCT, 2019-2028 (USD MILLION)

TABLE 5 global vial filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 6 globaL syringe filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 7 globaL cartridge filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 8 globaL others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By application, 2019-2028 (USD MILLION)

TABLE 10 global oncology IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 11 global infectious diseases IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 12 global cardiovascular disease IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 13 global metabolic diseases in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 14 global neurology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 15 global urology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 16 global dermatology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 17 global autoimmune diseases in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 18 global respiratory disorders in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 19 global others in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By end user, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL hospitals IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 22 global specialty clinics IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 23 global homecare setting IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 24 global others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 26 global direct tender IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 27 global retail pharmacy IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 28 global online pharmacy IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 29 global others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 32 Asia-Pacific small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 33 Asia-Pacific small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 34 Asia-Pacific small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 35 Asia-Pacific small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 36 China small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 37 China small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 38 China small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 39 China small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 Japan small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 41 Japan small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 42 Japan small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 43 Japan small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 44 India small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 45 India small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 46 India small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 47 India small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 48 Australia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 49 Australia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 50 Australia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 51 Australia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 52 South Korea small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 53 South Korea small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 54 South Korea small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 55 South Korea small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 Singapore small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 57 Singapore small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 58 Singapore small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 59 Singapore small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 New Zealand small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 61 New Zealand small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 62 New Zealand small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 63 New Zealand small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 64 Thailand small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 65 Thailand small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 66 Thailand small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 67 Thailand small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 68 Malaysia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 69 Malaysia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 70 Malaysia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 71 Malaysia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 Indonesia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 73 Indonesia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 74 Indonesia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 75 Indonesia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 76 Philippines small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 77 Philippines small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 78 Philippines small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 79 Philippines small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 80 Vietnam small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 81 Vietnam small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 82 Vietnam small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 83 Vietnam small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 84 Rest of Asia-Pacific small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 85 EUROPE small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 86 Europe small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 87 Europe small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 88 Europe small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 89 Europe small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 90 Germany small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 91 Germany small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 92 Germany small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 93 Germany small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 94 France small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 95 France small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 96 France small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 97 France small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 98 U.K. small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 99 U.K. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 100 U.K. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 101 U.K. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 Italy small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 103 Italy small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 104 Italy small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 105 Italy small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 106 Spain small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 107 Spain small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 108 Spain small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 109 Spain small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 110 Netherlands small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 111 Netherlands small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 112 Netherlands small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 113 Netherlands small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 114 Russia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 115 Russia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 116 Russia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 117 Russia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 118 Switzerland small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 119 Switzerland small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 120 Switzerland small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 121 Switzerland small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 122 Belgium small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 123 Belgium small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 124 Belgium small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 125 Belgium small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 126 Turkey small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 127 Turkey small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 128 Turkey small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 129 Turkey small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 Sweden small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 131 Sweden small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 132 Sweden small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 133 Sweden small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 Denmark small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 135 Denmark small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 136 Denmark small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 137 Denmark small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 138 POLAND small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 139 POLAND small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 140 POLAND small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 141 POLAND small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 142 REST OF Europe small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 143 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 144 Middle East and Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 145 Middle East and Africa small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 146 Middle East and Africa small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 147 Middle East and Africa small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 148 South Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 149 South Africa small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 150 South Africa small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 151 South Africa small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 152 Saudi Arabia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 153 Saudi Arabia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 154 Saudi Arabia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 155 Saudi Arabia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 156 U.A.E. small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 157 U.A.E. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 158 U.A.E. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 159 U.A.E. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 Egypt small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 161 Egypt small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 162 Egypt small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 163 Egypt small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 164 Israel small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 165 Israel small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 166 Israel small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 167 Israel small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 168 Ethiopia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 169 Ethiopia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 170 Ethiopia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 171 Ethiopia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 172 Rest of Middle East & Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 173 NORTH AMERICA small molecule sterile injectable drugs market, By country, 2019-2028 (USD Million)

TABLE 174 North America small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 175 North America small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 176 North America small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 177 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Product, 2019-2028 (USD Million)

TABLE 178 U.S. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 179 U.S. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 180 U.S. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 181 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 182 Canada small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 183 Canada small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 184 Canada small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 185 Mexico small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 186 Mexico small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 187 Mexico small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 188 Mexico small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 189 SOUTH AMERICA small molecule sterile injectable drugs market, By COUNTRY, 2021-2028 (USD million)

TABLE 190 SOUTH AMERICA Small molecule sterile injectable drugs Market, By product, 2019-2028 (USD Million)

TABLE 191 South America small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 192 South America small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 193 South America small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 194 Brazil small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 195 Brazil small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 196 Brazil small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 197 Brazil small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 198 ARGENTINA Small molecule sterile injectable drugsMarket, By product, 2019-2028 (USD Million)

TABLE 199 ARGENTINA small molecule sterile injectable drugs market, By applicatiob, 2019-2028 (USD Million)

TABLE 200 Argentina small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 201 ARGENTINA Small molecule sterile injectable drugsMarket, By Distribution Channel, 2019-2028 (USD Million)

TABLE 202 Rest Of South America small molecule sterile injectable drugs market, By Type, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DATA TRIANGULATION

FIGURE 3 global Small molecule sterile injectable drugs market: DROC ANALYSIS

FIGURE 4 Global Small molecule sterile injectable drugs market: Global VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Global Small molecule sterile injectable drugs market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Small molecule sterile injectable drugs market: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Small molecule sterile injectable drugs market: Product lifeline Curve

FIGURE 8 GLOBAL Small molecule sterile injectable drugs market: INTERVIEW DEMOGRAPHICS

FIGURE 9 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 10 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 GLOBAL Small molecule sterile injectable drugs market: MARKET End user COVERAGE GRID

FIGURE 12 Global Small molecule sterile injectable drugs market: SEGMENTATION

FIGURE 13 NORTH AMERICA is expected to DOMINATE THE GLOBAL Small molecule sterile injectable drugs market, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 THE growing geriatric population is expected to DRIVe THE global Small molecule sterile injectable drugs market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 15 PRODUCT SEGMENT is expected to account for the largest share of the global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET THE FORECAST PERIOD OF 2021 to 2028

FIGURE 16 Asia-pacific is the fastest-growing market FOR the Global Small molecule sterile injectable drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF Global immunoassays-gamma counter Market

FIGURE 18 The graph below shows the increasing prevalence of chronic diseases in 1995 to forecast 2030 in the U.S.

FIGURE 19 Global Small molecule sterile injectable drugs market: BY Product, 2020

FIGURE 20 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY Product, 2021-2028 (USD MILLION)

FIGURE 21 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY Product, CAGR (2021-2028)

FIGURE 22 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 23 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, 2020

FIGURE 24 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, 2021-2028 (USD MILLION)

FIGURE 25 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, CAGR (2021-2028)

FIGURE 26 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, LIFELINE CURVE

FIGURE 27 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, 2020

FIGURE 28 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, 2021-2028 (USD MILLION)

FIGURE 29 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, CAGR (2021-2028)

FIGURE 30 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, LIFELINE CURVE

FIGURE 31 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, 2020

FIGURE 32 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 33 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 34 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 35 Global small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 36 Global small molecule sterile injectable drugs market: BY REGION (2020)

FIGURE 37 Global small molecule sterile injectable drugs market: BY REGION (2021 & 2028)

FIGURE 38 Global small molecule sterile injectable drugs market: BY REGION (2020 & 2028)

FIGURE 39 Global small molecule sterile injectable drugs market: BY product (2021-2028)

FIGURE 40 ASIA-PACIFIC small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 41 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 42 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 43 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 44 ASIA-PACIFIC small molecule sterile injectable drugs market: BY product (2021-2028)

FIGURE 45 EUROPE small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 46 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 47 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 48 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 49 EUROPE small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 50 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 51 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 52 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 53 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 54 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 55 North AMERICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 56 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 57 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 58 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 59 North AMERICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 60 SOUTH AMERICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 61 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 62 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 63 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 64 SOUTH AMERICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 65 Global small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 66 North America small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 67 EUROPE small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 68 ASIA-PACIFIC small molecule sterile injectable drugs Market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Small Molecule Sterile Injectable Drugs Market size will be worth USD 2,73,421.52 million during the forecast period.
The Small Molecule Sterile Injectable Drugs Market growth rate is 7.2% during the forecast period.
Advancements in Biotechnology Expanding Treatment Options & Rising Chronic Disease Burden Needs Effective Treatment are the growth drivers of the Small Molecule Sterile Injectable Drugs Market.
The product, route of administration, application, end-users, and distribution channels are the factors on which the Small Molecule Sterile Injectable Drugs Market research is based.
The major companies in the Small Molecule Sterile Injectable Drugs Market are Gilead Sciences, Inc. (U.S.), BioCryst Pharmaceuticals, Inc. (U.S.), AstraZeneca (U.K.), Genentech, Inc. (U.S.), Merck KGaA (Germany), Hikma Pharmaceuticals PLC (U.K.), AbbVie Inc. (U.S.), American Regent, Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Teligent. (U.S.), Eisai Co., Ltd. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Neuren Pharmaceuticals (Australia), Noxopharm (Australia), Amomed Pharma GmbH (Austria), Sanofi (France), Exelixis, Inc. (U.S.), Fresenius Kabi USA (U.S.), Pfizer Inc. (U.S.).

関連ページを閲覧する

Banner